DSE : RENATA
Renata PLC — Key statistics
Pharmaceutical Preparations · Bangladesh
Last price 425.9 BDT (At close: Oct 29, 2026) · Market cap 48.85B
Latest research: Renata valuation report: fair value BDT 146–350 (Oct 2026) · Renata's FY2026 recovery is real, but a 10% return on equity supports BDT 146–350 a share (base 234)
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Technical report: trend, RSI, support and resistance, charts
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 48.85B |
| Enterprise Value | 64.51B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Nov 16, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 114.70M |
| Shares Outstanding | 114.70M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 63.54% |
| Float | 34.09M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 13.41 |
| Forward PE | 13.95 |
| PS Ratio | 1.06 |
| PB Ratio | 1.19 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | 18.76 |
| P/OCF Ratio | 8.54 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 17.71 |
| EV / Sales | 1.40 |
| EV / EBITDA | 8.24 |
| EV / EBIT | 11.06 |
| EV / FCF | 24.77 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.44 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 1.84 |
| Debt / FCF | 5.53 |
| Interest Coverage | 4.44 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 9.58% |
| Return on Assets (ROA) | 6.04% |
| Return on Invested Capital (ROIC) | 8.94% |
| Return on Capital Employed (ROCE) | 10.99% |
| Weighted Average Cost of Capital (WACC) | 5.11% |
| Revenue Per Employee | 5.32M |
| Profits Per Employee | 419,638 |
| Employee Count | 8,681 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 1.97 |
Taxes
| Measure | Value |
|---|
| Income Tax | 760.22M |
| Effective Tax Rate | 17.27% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.03 |
| 52-Week Price Change | -2.56% |
| 50-Day Moving Average | 452.92 |
| 200-Day Moving Average | 438.05 |
| Relative Strength Index (RSI) | 22.48 |
| Average Volume (20 Days) | 14,832 |
Shortselling
| Measure | Value |
|---|
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Incomestatement
| Measure | Value |
|---|
| Revenue | 46.20B |
| Gross Profit | 20.57B |
| Operating Income | 5.83B |
| Pretax Income | 4.40B |
| Net Income | 3.64B |
| EBITDA | 7.81B |
| EBIT | 5.83B |
| Earnings Per Share (EPS) | 31.76 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.98B |
| Total Debt | 14.39B |
| Net Cash | -12.41B |
| Net Cash Per Share | -108.16 |
| Equity (Book Value) | 41.01B |
| Book Value Per Share | 329.19 |
| Working Capital | 12.42B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 5.72B |
| Capital Expenditures | -3.12B |
| Depreciation & Amortization | 1.98B |
| Net Borrowing | -4.61B |
| Free Cash Flow | 2.60B |
| FCF Per Share | 22.70 |
Margins
| Measure | Value |
|---|
| Gross Margin | 44.52% |
| Operating Margin | 12.63% |
| Pretax Margin | 9.53% |
| Profit Margin | 7.88% |
| EBITDA Margin | 16.91% |
| EBIT Margin | 12.63% |
| FCF Margin | 5.64% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | 5.50 |
| Dividend Yield | 1.29% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 17.45% |
| FCF Payout Ratio | 24.23% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.29% |
| Earnings Yield | 7.46% |
| FCF Yield | 5.33% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | 615.05 |
| Price Target Difference | 44.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 15.51% |
| EPS Growth Forecast (3Y) | 21.42% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Nov 13, 2022 |
| Split Type | Forward |
| Split Ratio | 1.07 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.6 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |